BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

917 related articles for article (PubMed ID: 15590768)

  • 1. High-affinity epibatidine binding of functional, human alpha7-nicotinic acetylcholine receptors stably and heterologously expressed de novo in human SH-EP1 cells.
    Peng JH; Fryer JD; Hurst RS; Schroeder KM; George AA; Morrissy S; Groppi VE; Leonard SS; Lukas RJ
    J Pharmacol Exp Ther; 2005 Apr; 313(1):24-35. PubMed ID: 15590768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of human alpha 4 beta 2-nicotinic acetylcholine receptors stably and heterologously expressed in native nicotinic receptor-null SH-EP1 human epithelial cells.
    Eaton JB; Peng JH; Schroeder KM; George AA; Fryer JD; Krishnan C; Buhlman L; Kuo YP; Steinlein O; Lukas RJ
    Mol Pharmacol; 2003 Dec; 64(6):1283-94. PubMed ID: 14645658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inducible, heterologous expression of human alpha7-nicotinic acetylcholine receptors in a native nicotinic receptor-null human clonal line.
    Peng JH; Lucero L; Fryer J; Herl J; Leonard SS; Lukas RJ
    Brain Res; 1999 Apr; 825(1-2):172-9. PubMed ID: 10216184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methadone is a non-competitive antagonist at the α4β2 and α3* nicotinic acetylcholine receptors and an agonist at the α7 nicotinic acetylcholine receptor.
    Talka R; Salminen O; Tuominen RK
    Basic Clin Pharmacol Toxicol; 2015 Apr; 116(4):321-8. PubMed ID: 25196810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term exposure to the new nicotinic antagonist 1,2-bisN-cytisinylethane upregulates nicotinic receptor subtypes of SH-SY5Y human neuroblastoma cells.
    Riganti L; Matteoni C; Di Angelantonio S; Nistri A; Gaimarri A; Sparatore F; Canu-Boido C; Clementi F; Gotti C
    Br J Pharmacol; 2005 Dec; 146(8):1096-109. PubMed ID: 16273122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional properties of homomeric, human alpha 7-nicotinic acetylcholine receptors heterologously expressed in the SH-EP1 human epithelial cell line.
    Zhao L; Kuo YP; George AA; Peng JH; Purandare MS; Schroeder KM; Lukas RJ; Wu J
    J Pharmacol Exp Ther; 2003 Jun; 305(3):1132-41. PubMed ID: 12626641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of chronic drug treatment on alpha3* and alpha7 nicotinic receptor binding sites, in hippocampal neurones and SH-SY5Y cells.
    Ridley DL; Rogers A; Wonnacott S
    Br J Pharmacol; 2001 Aug; 133(8):1286-95. PubMed ID: 11498514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion of the alpha7, beta2, or beta4 nicotinic receptor subunit genes identifies highly expressed subtypes with relatively low affinity for [3H]epibatidine.
    Marks MJ; Whiteaker P; Collins AC
    Mol Pharmacol; 2006 Sep; 70(3):947-59. PubMed ID: 16728647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rat neuronal nicotinic acetylcholine receptors containing alpha7 subunit: pharmacological properties of ligand binding and function.
    Xiao Y; Abdrakhmanova GR; Baydyuk M; Hernandez S; Kellar KJ
    Acta Pharmacol Sin; 2009 Jun; 30(6):842-50. PubMed ID: 19448648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Similarity between rat brain nicotinic alpha-bungarotoxin receptors and stably expressed alpha-bungarotoxin binding sites.
    Quik M; Choremis J; Komourian J; Lukas RJ; Puchacz E
    J Neurochem; 1996 Jul; 67(1):145-54. PubMed ID: 8666985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic deletion of the adenosine A(2A) receptor prevents nicotine-induced upregulation of α7, but not α4β2* nicotinic acetylcholine receptor binding in the brain.
    Metaxas A; Al-Hasani R; Farshim P; Tubby K; Berwick A; Ledent C; Hourani S; Kitchen I; Bailey A
    Neuropharmacology; 2013 Aug; 71():228-36. PubMed ID: 23583933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methadone increases intracellular calcium in SH-SY5Y and SH-EP1-halpha7 cells by activating neuronal nicotinic acetylcholine receptors.
    Pakkanen JS; Nousiainen H; Yli-Kauhaluoma J; Kylänlahti I; Möykkynen T; Korpi ER; Peng JH; Lukas RJ; Ahtee L; Tuominen RK
    J Neurochem; 2005 Sep; 94(5):1329-41. PubMed ID: 16000156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective analgesic acting via neuronal nicotinic acetylcholine receptors: I. In vitro characterization.
    Donnelly-Roberts DL; Puttfarcken PS; Kuntzweiler TA; Briggs CA; Anderson DJ; Campbell JE; Piattoni-Kaplan M; McKenna DG; Wasicak JT; Holladay MW; Williams M; Arneric SP
    J Pharmacol Exp Ther; 1998 May; 285(2):777-86. PubMed ID: 9580626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rat alpha3/beta4 subtype of neuronal nicotinic acetylcholine receptor stably expressed in a transfected cell line: pharmacology of ligand binding and function.
    Xiao Y; Meyer EL; Thompson JM; Surin A; Wroblewski J; Kellar KJ
    Mol Pharmacol; 1998 Aug; 54(2):322-33. PubMed ID: 9687574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [3H]A-585539 [(1S,4S)-2,2-dimethyl-5-(6-phenylpyridazin-3-yl)-5-aza-2-azoniabicyclo[2.2.1]heptane], a novel high-affinity alpha7 neuronal nicotinic receptor agonist: radioligand binding characterization to rat and human brain.
    Anderson DJ; Bunnelle W; Surber B; Du J; Surowy C; Tribollet E; Marguerat A; Bertrand D; Gopalakrishnan M
    J Pharmacol Exp Ther; 2008 Jan; 324(1):179-87. PubMed ID: 17959745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of nicotinic receptor subunit composition upon agonist, alpha-bungarotoxin and insecticide (imidacloprid) binding affinity.
    Lansdell SJ; Millar NS
    Neuropharmacology; 2000 Feb; 39(4):671-9. PubMed ID: 10728888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicotine-morphine interactions at α4β2, α7 and α3(⁎) nicotinic acetylcholine receptors.
    Talka R; Salminen O; Whiteaker P; Lukas RJ; Tuominen RK
    Eur J Pharmacol; 2013 Feb; 701(1-3):57-64. PubMed ID: 23340223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Norchloro-fluoro-homoepibatidine: specificity to neuronal nicotinic acetylcholine receptor subtypes in vitro.
    Deuther-Conrad W; Patt JT; Feuerbach D; Wegner F; Brust P; Steinbach J
    Farmaco; 2004 Oct; 59(10):785-92. PubMed ID: 15474055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological and functional comparisons of α6/α3β2β3-nAChRs and α4β2-nAChRs heterologously expressed in the human epithelial SH-EP1 cell line.
    Chen DJ; Gao FF; Ma XK; Shi GG; Huang YB; Su QX; Sudweeks S; Gao M; Dharshaun T; Eaton JB; Chang YC; Mcintosh JM; Lukas RJ; Whiteaker P; Steffensen SC; Wu J
    Acta Pharmacol Sin; 2018 Oct; 39(10):1571-1581. PubMed ID: 29795357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotine exposure during a critical period of development leads to persistent changes in nicotinic acetylcholine receptors of adult rat brain.
    Miao H; Liu C; Bishop K; Gong ZH; Nordberg A; Zhang X
    J Neurochem; 1998 Feb; 70(2):752-62. PubMed ID: 9453571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.